Indian Police Accuse Chinese Telcos of Funding Investigated News Portal
Indian police have accused Chinese smartphone manufacturers Xiaomi and Vivo of illegally transferring funds to NewsClick, a news portal under investigation for allegedly spreading Chinese propaganda. The police complaint, filed in August and shared recently, claims that large amounts of funds were received from China to push biased news. Xiaomi India has strongly denied the allegations, and NewsClick has labeled the accusations as “untenable and bogus.” The case is seen by some as part of a broader crackdown on the press, a claim the government denies.
India Tells YouTube, Telegram to Remove Child Sexual Abuse Material
India’s Ministry of Electronics and Information Technology has ordered X, YouTube and Telegram to remove any content related to child sexual abuse from their platforms. This move is part of a broader initiative to combat online child exploitation. The ministry has also urged the platforms to strengthen their mechanisms for preventing the upload of such content, emphasising the need for proactive measures to protect children online.
See Also: Is Olectra Greentech Share A Good Buy?
India’s Markets Regulator Permits MCX to Launch New Derivatives Platform
India’s markets regulator has granted permission to the Multi Commodity Exchange of India (MCX) to launch a new derivatives platform. This approval is expected to enhance the diversity of financial products available to investors and could lead to increased trading volumes on the exchange. The introduction of the new derivatives platform aligns with ongoing efforts to deepen India’s financial markets and provide investors with a broader range of instruments for hedging and trading.
BCCI Faces Flak Over World Cup Ticket Sales, Poor Attendance
The Board of Control for Cricket in India (BCCI) is facing criticism over the handling of ticket sales for the World Cup, leading to poor attendance at matches. Fans and cricket enthusiasts have expressed disappointment, attributing the low turnout to the inefficient ticketing system. The issue has sparked discussions on social media, with many calling for improvements to ensure cricket lovers can easily access tickets and support their teams.
Sun Pharma, Aurobindo Recall Drugs from US Market
Sun Pharma and Aurobindo Pharma are recalling specific drug batches from the US market, PTI reported. The recall by Sun Pharma involves a generic version of diabetes medication due to the presence of a cancer-causing impurity above acceptable levels. Aurobindo is recalling a batch of its gabapentin capsules, used to treat nerve pain and seizures, due to deviations from the standard manufacturing practices. The recalls are voluntary, and efforts are underway to remove the affected batches from the market.
Read Next: Best Bikes Under ₹1 Lakh: A Definitive List
Don't miss a beat on the share market. Get real-time updates on top stock movers and trading ideas on Benzinga India Telegram channel.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.